SEC Form 4/A · accession 0001613377-17-000004
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Wayne S. Springate
Officer — Sr VP of Operations
Period of report
Feb 16, 2017
Accepted (ET)
Feb 21, 2017 · 3:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 16, 2017 | P | 8,014 | $0.46 | A | 16,641 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount of securities beneficially owned following the reported transaction was incorrect when filed earlier today (2/21/17).